Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-24
DOI
10.1007/s10549-019-05289-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial
- (2018) Cesar A. Santa-Maria et al. BREAST CANCER RESEARCH AND TREATMENT
- Postmenopausal osteoporosis: Assessment and management
- (2018) René Rizzoli BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone health evaluation one year after aromatase inhibitors completion
- (2018) Marta Pineda-Moncusí et al. BONE
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
- (2018) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Adverse impacts of chronic pain on health-related quality of life, work productivity, depression and anxiety in a community-based study
- (2017) Kosuke Kawai et al. FAMILY PRACTICE
- Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis
- (2017) Hadar Goldvaser et al. JNCI-Journal of the National Cancer Institute
- Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis
- (2017) Hadar Goldvaser et al. JNCI-Journal of the National Cancer Institute
- AI-related BMD variation in actual practice conditions: A prospective cohort study
- (2016) María Rodríguez-Sanz et al. ENDOCRINE-RELATED CANCER
- Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
- (2016) Kunal C. Kadakia et al. ONCOLOGIST
- The Correlations between Health-Related Quality of Life Changes and Pain and Anxiety in Orthodontic Patients in the Initial Stage of Treatment
- (2015) Jing Wang et al. Biomed Research International
- Aromatase inhibitor-induced arthralgia: a review
- (2013) P. Niravath ANNALS OF ONCOLOGY
- Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
- (2013) Natalia Garcia-Giralt et al. BREAST CANCER RESEARCH AND TREATMENT
- Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study
- (2013) Francoise Laroche et al. JOURNAL OF PAIN
- Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer
- (2012) N. Lynn Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer
- (2011) Sònia Servitja et al. BREAST
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
- (2011) Meredith M Regan et al. LANCET ONCOLOGY
- Validity of four pain intensity rating scales
- (2011) Maria Alexandra Ferreira-Valente et al. PAIN
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF
- (2011) Gillian A. Hawker et al. ARTHRITIS CARE & RESEARCH
- Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study
- (2010) Daniel Prieto-Alhambra et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
- (2009) Ethan Basch et al. JNCI-Journal of the National Cancer Institute
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search